Search
Searching Content indexed under Trials & Appeals & Compensation by Smart & Biggar ordered by Published Date Descending.
Links to Result pages
 
1 2 3 4  
>>Next
 
Title
Country
Organisation
Author
Date
2
The Experimental Use Exception Under The Recently Amended Canadian Patent Act
Canada recently introduced new legislation (The Budget Implementation Act, 2018, No. 2) which brought about several changes to the Patent Act affecting the scope of protection available under Canadian patents.
Canada
26 Sep 2019
3
Federal Court Of Appeal Dismisses First PMNOC Interlocutory Appeal Granted Leave
Most interlocutory decisions under the Patented Medicines (Notice of Compliance) Regulations (PMNOC Regulations) are made by prothonotaries of the Federal Court (FC).
Canada
5 Aug 2019
4
Federal Court Upholds PMPRB's Pricing Decision Regarding Alexion's SOLIRIS
On June 12, 2019, Justice Gleeson dismissed Alexion's application for judicial review of a Panel of the Patented Medicines Price Review Board (PMPRB)'s (i) decision
Canada
10 Jul 2019
5
New Court Proceedings - March 2019
New Court Proceedings - March 2019
Canada
15 Apr 2019
6
Supreme Court Of Canada Denies Apotex Leave To Appeal Federal Court Of Appeal's Rejection Of Judicial Review Of Health Canada Decision Regarding India Facilities
As previously reported, the Federal Court of Appeal (FCA) dismissed Apotex's appeal of a judicial review decision of the Therapeutic Products Directorate (TPD) ...
Canada
15 Apr 2019
7
Federal Court Finds Invalidity Allegations Relating To Patent For Metformin Formulations Not Justified
On March 8, 2019, Justice Fothergill granted Valeant Canada's application for an order prohibiting the Minister of Health from issuing a notice of compliance to Generic Partners for its generic version...
Canada
15 Apr 2019
8
Ontario Court Of Appeal Dismisses Appeal Of Judgment Awarding Apotex Damages From Contract Research Organization For Delayed FDA approval Of Two Products
As previously reported, in December 2017, Apotex was awarded over $11M in damages and pre-judgment interest for losses flowing from delays ...
Canada
8 Mar 2019
9
Apotex Seeks Leave From Supreme Court Of Canada In Cefaclor Damages Action
As previously reported, the Federal Court of Appeal (FCA) allowed in part Apotex's appeal of a decision awarding Eli Lilly over $100 million for Apotex's infringement ...
Canada
8 Mar 2019
10
Orders Of Prohibition Relating To Polymorphic Form Patent For PRISTIQ Upheld On Appeal
As previously reported, the Federal Court, in a pair of decisions, granted orders prohibiting Apotex and Teva from marketing their generic o-desmethyl-venlafaxine succinate products until expiry of Patent No. 2,436,668.
Canada
7 Mar 2019
11
New Court Proceedings - January 2019
For complete details about these proceedings, click here.
Canada
5 Feb 2019
12
Apotex Seeks Leave To Appeal Ramipril Pleadings Amendment Decision
As previously reported, the Ontario Court of Appeal (ONCA) granted Sanofi and Schering leave to amend their defences to plead the Supreme Court of Canada's decision ...
Canada
5 Feb 2019
13
Under Reserve: Appeal From Judicial Review Quashing PMPRB Decision On Jurisdiction Over DIFFERIN
On January 17, 2019, the Federal Court of Appeal heard the Attorney General of Canada's appeal from a judicial review that quashed a Board decision that it has jurisdiction ...
Canada
5 Feb 2019
14
Year-End Round-Up: Notable Trademark Case Law From 2018
Earlier this month we also issued a round-up of notable patent decisions from the last year, and our 2018 highlights in Canadian Life Sciences IP covers decisions on the merits in that space.
Canada
4 Feb 2019
15
Year-End Round-Up: Notable Canadian Patent Cases Of 2018
Earlier this month we published an exhaustive review of the life sciences and regulatory cases in the Canadian courts, and decisions on the merits ...
Canada
29 Jan 2019
16
New Court Proceedings - December 2018
For complete details about these proceedings, click here.
Canada
28 Dec 2018
17
FCA Overturns Cefaclor Damages Decision On Prejudgment Interest Issue, Provides Guidance On NIA Defence
On November 23, 2018, the Federal Court of Appeal (FCA) allowed in part Apotex's appeal of a decision awarding Eli Lilly over $100 million for Apotex's infringement of eight process patents ...
Canada
28 Dec 2018
18
New Court Proceedings - November 2018
For complete details about these proceedings, click here.
Canada
6 Dec 2018
19
Supreme Court Of Canada Leave Applications - November 2018
Supreme Court of Canada denies Eli Lilly leave to appeal in olanzapine section 8 damages action.
Canada
6 Dec 2018
20
Ontario Court Of Appeal Allows Sanofi And Schering To Plead That Federal Court Ramipril Patent Invalidity Decision Was Flawed Due To "Promise Doctrine"
In an action by Apotex for compensation from Sanofi and Schering under the Ontario Statute of Monopolies, U.K. Statute of Monopolies and the Trade-marks Act ...
Canada
6 Dec 2018
Links to Result pages
 
1 2 3 4  
>>Next